SEC Form 4/A · accession 0001192482-15-000318

Recro Pharma, Inc. · REPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.

Reporting owner

Officer — President and CEO · Director

Period of report

Dec 17, 2014

Accepted (ET)

Jul 28, 2015 · 3:49 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001588972

Table I — non-derivative securities

No Table I lines on this filing.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1,F2	$2.47	Dec 17, 2014	A	123,500	A	—	Dec 17, 2024	Common Stock	123,500	123,500	D
Employee Stock Option (right to buy)^F3,F1,F4	$2.47	Jul 25, 2015	A	123,500	A	—	Dec 17, 2024	Common Stock	123,500	123,500	D

F1The option was granted on December 17, 2014, subject to shareholder approval at the Company's 2015 Annual Meeting of Shareholders of an amendment to increase the number of shares of common stock available for issuance under the Company's 2013 Equity Incentive Plan. Such shareholder approval was received on June 24, 2015.
F2Upon receipt of shareholder approval, 15,437 shares subject to such options vested immediately, and the remainder will vest monthly thereafter in equal proportions until December 17, 2018.
F3Amended to reflect correct transaction date.
F4The option was granted on December 17, 2014 and vests 30% upon satisfaction of certain performance conditions, and then monthly thereafter in equal proportions over a three-year period beginning on the date the performance conditions are satisfied. On July 25, 2015 the Compensation Committee of the Board of Directors of the Issuer determined that the performance criteria were met, resulting in vesting of 30% of the option and the beginning of the three-year monthly vesting period.